pyrimidin-2-one beta-ribofuranoside has been researched along with Uterine Cervical Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, P; Hanley, SJ; Ihira, K; Konno, Y; Kudo, M; Sakuragi, N; Suzuki, F; Watari, H; Xiong, Y; Yamada, T; Yue, J | 1 |
| Park, WH; You, BR | 1 |
2 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
Topics: Base Sequence; Cell Line, Tumor; Cell Proliferation; Cytidine; DNA Methylation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Intracellular Signaling Peptides and Proteins; MicroRNAs; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplastic Stem Cells; Oncogenes; Phenotype; Protein Binding; Repressor Proteins; Transcription, Genetic; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2016 |
Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Proliferation; Cytidine; DNA Modification Methylases; Drug Screening Assays, Antitumor; Female; Glutathione; HeLa Cells; Humans; Inhibitory Concentration 50; Membrane Potential, Mitochondrial; Oligopeptides; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Uterine Cervical Neoplasms | 2012 |